Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of recombinant ganoderma lucidum immunoregulatory protein in preparation of medicine for treating androgenetic alopecia

An immunoregulatory protein and androgenic technology, applied in drug combinations, peptide/protein components, pharmaceutical formulations, etc., can solve the problems of no AGA drug and high recurrence of AGA, and achieve good therapeutic effect, high safety, The effect of improving the symptoms of androgenic alopecia

Inactive Publication Date: 2015-07-01
张喜田 +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The various existing treatment methods for AGA have their limitations. In addition, AGA itself is a stubborn and recurrent disease. So far, no drug that can fundamentally treat AGA has been found.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of recombinant ganoderma lucidum immunoregulatory protein in preparation of medicine for treating androgenetic alopecia
  • Application of recombinant ganoderma lucidum immunoregulatory protein in preparation of medicine for treating androgenetic alopecia
  • Application of recombinant ganoderma lucidum immunoregulatory protein in preparation of medicine for treating androgenetic alopecia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1 rLZ-8 can improve the hair loss in mice induced by testosterone propionate.

[0021] 1 Experimental materials

[0022] rLZ-8 (provided by the Institute of Genetic Engineering Drugs of Jilin University), testosterone propionate injection (Shanghai General Pharmaceutical Co., Ltd.).

[0023] 2 Instruments and equipment

[0024] Grate, tweezers, ziplock bag, Canon camera.

[0025] 3 Experimental animals

[0026] Healthy and flexible ICR mice, half male and half female, weighing 20±2g, SPF grade. Purchased from the Basic Animal Center of Jilin University, animal license number: SCXK Beijing 2009-0004. Raised under SPF grade conditions of Jilin University. During the experiment, the room temperature was controlled at 20°C ± 2°C, the lighting was alternated for 12 hours, and the mice were given free access to water and food.

[0027] Animals were inspected for hair before administration, and 60 qualified mice were selected and randomly divided into 6 groups, 1...

Embodiment 2

[0038] Example 2 rLZ-8 can improve the secretion balance of sex hormones in mice and its influence on major organ indexes

[0039] 1 Experimental materials

[0040] rLZ-8 (provided by the Institute of Genetic Engineering Drugs of Jilin University), testosterone propionate injection (Shanghai General Pharmaceutical Co., Ltd.).

[0041] 2 Instruments and equipment

[0042] Low temperature centrifuge (eppendorf centrifuge 5810R), digital display constant temperature circulating water tank (Guohua HH-42 type), 752 type ultraviolet grating spectrophotometer (Shandong Gaomi Analytical Instrument Factory).

[0043] 3 Experimental animals

[0044] Healthy and flexible ICR mice, half male and half female, weighing 20±2g, SPF grade. Purchased from the Basic Animal Center of Jilin University, animal license number: SCXK Beijing 2009-0004. Raised under SPF grade conditions of Jilin University. During the experiment, the room temperature was controlled at 20°C ± 2°C, the lighting was ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of recombinant ganoderma lucidum immunoregulatory protein (rLZ-8) in androgenetic alopecia. In-vivo animal model experiments show that the recombinant ganoderma lucidum immunoregulatory protein is capable of improving depilation of an androgenetic alopecia anomal model and can be used for preventing and treating androgenetic alopecia. The recombinant ganoderma lucidum immunoregulatory protein disclosed by the invention is a high-purity protein substance prepared through a recombination technology and a yeast cell eukaryotic expression system.

Description

technical field [0001] The present invention relates to a new application of recombinant Ganoderma lucidum immunoregulatory protein expressed by Pichia pastoris in the treatment of androgenetic alopecia, in particular to the use of recombinant Ganoderma lucidum immunomodulatory protein in preventing, alleviating and / or treating androgenetic alopecia. The use in hormone-induced alopecia belongs to the field of biomedical engineering (biomedical field). Background technique [0002] Androgenetic Alopecia (AGA), also known as Seborrheic Alopecia (SA), Male Pattern Alopecia (MPA), is a common, frequently-occurring, and refractory disease in dermatology. One, the course of the disease is long and stubborn. The clinical symptoms often manifest as greasy hair, dandruff, obvious itching, progressive hair loss in the frontotemporal area and the top, and then form a "high forehead". Temporal hair is basically normal. Male pattern hair loss is a worldwide dermatological problem. Fro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/16A61P17/14A61P17/08
CPCA61K38/16
Inventor 孙非梁重阳张喜田
Owner 张喜田
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com